Technical Analysis for SEER - Seer, Inc.

Grade Last Price % Change Price Change
C 2.02 -9.42% -0.21
SEER closed up 0.9 percent on Wednesday, May 8, 2024, on 71 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup -9.42%
Earnings Movers Other -9.42%
Outside Day Range Expansion -9.42%
Wide Bands Range Expansion -9.42%
Overbought Stochastic Strength -9.42%
Gapped Down Weakness -9.42%
Bearish Engulfing Bearish -8.60%
Narrow Range Bar Range Contraction -8.60%
Upper Bollinger Band Walk Strength -8.60%
Inside Day Range Contraction -8.60%

   Recent Intraday Alerts

Alert Time
3x Volume Pace 5 minutes ago
2x Volume Pace 10 minutes ago
1.5x Volume Pace 10 minutes ago
Down 2 ATRs 10 minutes ago
Gapped Down (Full) 26 minutes ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Seer, Inc., a life sciences company, engages in developing nanoparticle technology solutions for researchers in the areas of proteomics information. The company develops Proteograph, an integrated solution comprising consumables, automation instrumentation, and proprietary software that performs proteomics analysis. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is based in Redwood City, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Proteomics Proprietary Software

Is SEER a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.65
52 Week Low 1.455
Average Volume 531,953
200-Day Moving Average 2.10
50-Day Moving Average 1.89
20-Day Moving Average 1.92
10-Day Moving Average 2.09
Average True Range 0.12
RSI (14) 69.70
ADX 31.31
+DI 31.48
-DI 11.05
Chandelier Exit (Long, 3 ATRs) 1.93
Chandelier Exit (Short, 3 ATRs) 1.98
Upper Bollinger Bands 2.34
Lower Bollinger Band 1.50
Percent B (%b) 0.87
BandWidth 43.58
MACD Line 0.11
MACD Signal Line 0.07
MACD Histogram 0.0465
Fundamentals Value
Market Cap 133.31 Million
Num Shares 59.8 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -1.56
Price-to-Sales 6.85
Price-to-Book 0.28
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.45
Resistance 3 (R3) 2.45 2.37 2.41
Resistance 2 (R2) 2.37 2.32 2.37 2.40
Resistance 1 (R1) 2.30 2.28 2.34 2.30 2.39
Pivot Point 2.23 2.23 2.25 2.23 2.23
Support 1 (S1) 2.16 2.17 2.19 2.16 2.07
Support 2 (S2) 2.08 2.14 2.08 2.06
Support 3 (S3) 2.01 2.08 2.05
Support 4 (S4) 2.01